CSPC Megalith Biopharmaceutical’s License Agreement with Elevation Oncology

Martina Bellini
Tagged:

Morrison Foerster advised CSPC Megalith Biopharmaceutical Co. on the deal.CSPC Megalith Biopharmaceutical Co., Ltd., a subsidiary of CSPC Pharmaceutical Group Limited (Stock code: 1093.HK) announced an exclusive…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Martina Bellini

Author: Martina Bellini

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here